These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 10344730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
    Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF.
    J Immunol; 1991 Mar 01; 146(5):1692-9. PubMed ID: 1671580
    [Abstract] [Full Text] [Related]

  • 3. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
    Crowley NJ, Slingluff CL, Darrow TL, Seigler HF.
    Cancer Res; 1990 Feb 01; 50(3):492-8. PubMed ID: 2404572
    [Abstract] [Full Text] [Related]

  • 6. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
    Yang S, Darrow TL, Seigler HF.
    Cancer Res; 1997 Apr 15; 57(8):1561-8. PubMed ID: 9108460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo.
    Drexler I, Antunes E, Schmitz M, Wölfel T, Huber C, Erfle V, Rieber P, Theobald M, Sutter G.
    Cancer Res; 1999 Oct 01; 59(19):4955-63. PubMed ID: 10519409
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T, Tachibana M, Horiguchi Y, Nakamura K, Ikeda Y, Takesako K, Murai M.
    Clin Cancer Res; 2001 Jan 01; 7(1):23-31. PubMed ID: 11205913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R, Abdel-Wahab Z, Seigler HF, Darrow TL.
    Cell Immunol; 2001 Jun 15; 210(2):96-105. PubMed ID: 11520076
    [Abstract] [Full Text] [Related]

  • 14. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen.
    Sun Y, Song M, Stevanović S, Jankowiak C, Paschen A, Rammensee HG, Schadendorf D.
    Int J Cancer; 2000 Aug 01; 87(3):399-404. PubMed ID: 10897046
    [Abstract] [Full Text] [Related]

  • 15. Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein.
    Weng X, Lu S, Zhong M, Liang Z, Shen G, Chen J, Wu X.
    J Leukoc Biol; 2009 Mar 01; 85(3):574-81. PubMed ID: 19112092
    [Abstract] [Full Text] [Related]

  • 16. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.
    Chakraborty NG, Chattopadhyay S, Mehrotra S, Chhabra A, Mukherji B.
    Hum Immunol; 2004 Aug 01; 65(8):794-802. PubMed ID: 15336780
    [Abstract] [Full Text] [Related]

  • 17. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.
    Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG.
    Cancer Res; 1999 Nov 15; 59(22):5785-92. PubMed ID: 10582700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
    Zarour HM, Storkus WJ, Brusic V, Williams E, Kirkwood JM.
    Cancer Res; 2000 Sep 01; 60(17):4946-52. PubMed ID: 10987311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.